New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- 135 Wood Street
- West Haven CT, 06516
- UNITED STATES
NanoViricides applies nanomedicine technologies to the treatment of viral diseases. The nanoviricide® has a peptide on its surface that the company designs which mimics what's expressed on the surface of the target cell of the virus. The attachment of the surface protein of the virus to the "mimic" causes a conformational change in the nanoviricide® which then encapsulates the virus, destroying it. This has been demonstrated in over 4000 animals with 9 different viral-induced diseases.